NIH: Ebola Vaccine in the Works
the MPR take:
The National Institutes of Health (NIH) has announced that they will begin clinical trials on an experimental Ebola vaccine in humans as early as September. The vaccine has been in development for the past few years and has produced promising results in animal trials. Other vaccines are also in development, including one as a post-exposure treatment and another that has been almost 100% effective in preventing infection in monkeys. The FDA approval process for vaccines can take years but exceptions are made to fast-track development and approval under certain circumstances such as the current Ebola epidemic, which has been called the worst outbreak of the virus in history.
(CNN) -- The National Institutes of Health will begin testing an experimental Ebola vaccine in people as early as September, the NIH announced Thursday. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, said NIH has been working with the Food and Drug Administration to get the vaccine into early trials as soon as possible.
READ FULL ARTICLE From CNN